American Century Companies Inc. Cuts Holdings in MEDIFAST INC $MED

American Century Companies Inc. cut its stake in MEDIFAST INC (NYSE:MED) by 7.9% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 224,945 shares of the specialty retailer’s stock after selling 19,240 shares during the quarter. American Century Companies Inc. owned about 2.05% of MEDIFAST worth $3,032,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in the stock. Charles Schwab Investment Management Inc. raised its position in MEDIFAST by 132.7% in the first quarter. Charles Schwab Investment Management Inc. now owns 265,572 shares of the specialty retailer’s stock valued at $3,580,000 after purchasing an additional 151,434 shares during the period. Two Sigma Investments LP grew its stake in MEDIFAST by 11.4% in the fourth quarter. Two Sigma Investments LP now owns 232,069 shares of the specialty retailer’s stock worth $4,089,000 after purchasing an additional 23,822 shares in the last quarter. Two Sigma Advisers LP boosted its stake in MEDIFAST by 86.0% in the fourth quarter. Two Sigma Advisers LP now owns 216,000 shares of the specialty retailer’s stock valued at $3,806,000 after acquiring an additional 99,900 shares during the period. Northern Trust Corp boosted its stake in MEDIFAST by 0.9% in the fourth quarter. Northern Trust Corp now owns 101,775 shares of the specialty retailer’s stock valued at $1,793,000 after acquiring an additional 871 shares during the period. Finally, Peapod Lane Capital LLC acquired a new position in MEDIFAST in the first quarter valued at approximately $933,000. 95.51% of the stock is owned by hedge funds and other institutional investors.

MEDIFAST Stock Up 0.3%

Shares of MED stock opened at $14.06 on Friday. The business has a 50 day moving average of $13.93 and a two-hundred day moving average of $13.69. The company has a market cap of $154.52 million, a P/E ratio of 43.94 and a beta of 0.80. MEDIFAST INC has a 52 week low of $11.57 and a 52 week high of $21.98.

MEDIFAST (NYSE:MED) last issued its quarterly earnings data on Monday, August 4th. The specialty retailer reported $0.04 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.22) by $0.26. The business had revenue of $105.56 million during the quarter, compared to the consensus estimate of $96.10 million. MEDIFAST had a return on equity of 2.00% and a net margin of 0.76%. MEDIFAST has set its Q3 2025 guidance at -0.600-0.00 EPS. Analysts expect that MEDIFAST INC will post 0.51 EPS for the current fiscal year.

MEDIFAST Profile

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.